Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
J. Jefferson Smith | Chief Research Officer | 2024-01-23 | 28,000 | $0.37 | $10.36kSell |
Michael Amoroso | President and CEO | 2024-01-22 | 137,390 | $0.36 | $49.46kSell |
Alan List | Chief Medical Officer | 2024-01-22 | 21,526 | $0.36 | $7.75kSell |
Dario Scimeca | General Counsel and Secretary | 2024-01-22 | 21,287 | $0.36 | $7.66kSell |
Michael Amoroso | President and CEO | 2023-11-03 | 125,025 | $0.40 | $50.01kSell |
Dario Scimeca | General Counsel and Secretary | 2023-11-03 | 16,023 | $0.40 | $6.41kSell |
John Alexander Kelly | Chief Financial Officer | 2023-08-31 | 5,951 | $0.39 | $2.32kBuy |
Dario Scimeca | General Counsel and Secretary | 2023-08-31 | 5,443 | $0.39 | $2.12kBuy |
J. Jefferson Smith | Chief Research Officer | 2023-08-31 | 5,175 | $0.39 | $2.02kBuy |
John Alexander Kelly | Chief Financial Officer | 2023-08-18 | 90,000 | $0.48 | $43.20kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Pharma Ag Novartis | 179.40% | 12,407,440 | $120.10M | Insider |
Capital World Investors | 74.02% | 5,119,458 | $49.56M | Institution |
Vanguard Group Inc | 68.75% | 4,754,776 | $46.03M | Institution |
Venbio Global Strategic Fund LP | 61.67% | 4,265,141 | $41.29M | Insider |
Derek Jantz | 58.63% | 4,055,174 | $39.25M | Insider |
Fmr LLC | 54.05% | 3,738,248 | $36.19M | Insider |
Citadel Advisors LLC | 50.11% | 3,465,763 | $33.55M | Institution |
Tang Capital Management LLC | 49.16% | 3,400,000 | $32.91M | Institution |
Acadian Asset Management LLC | 48.35% | 3,343,914 | $32.37M | Institution |
Renaissance Technologies LLC | 37.47% | 2,591,212 | $25.08M | Institution |